Measurement Issues in Quality-of-Life Assessments

Claudette G. Varricchio

ONF 2006, 33(1), 13-21. DOI: 10.1188/06.ONF.S1.13-21

Purpose/Objectives: To describe issues to be considered when measuring the quality of life (QOL) of patients with cancer.

Data Sources: Published articles and books, conference proceedings, and abstracts.

Data Synthesis: A review of the existing literature reveals an emerging field of research and considerable discussion of measurement issues. Consensus is growing about measurement approaches to this subjective concept; however, agreement differs regarding specific aspects of measurement approaches and interpretation of data.

Conclusions: The purpose of the QOL assessment and how the data will be analyzed are the main determinants of the choice of assessment and measurement approaches. Differences regarding how QOL is measured may be encountered based on a clinical or research purpose.

Implications for Nursing: QOL assessments may be used as part of data collection to address a specific research question or may be used to guide clinical practice. Research findings used to guide clinical practice should be evaluated for validity, reliability, and fit of the sample before being incorporated into clinical practice. QOL assessment in clinical practice may be used as an exploratory tool to identify potential problems or may be used to evaluate the effectiveness of a targeted intervention.

Jump to a section

    References

    Aaronson, N.K., Admedzai, S., Bergman, B., Bullinger, M., Cull, A., Duez, N.J., et al. (1993). The European Organization for Research and Treatment of Cancer QLQ-C30: A quality-of-life instrument for use in international clinical trials in oncology. Journal of the National Cancer Institute, 85, 365-376.

    Berger, A.M., Berry, D.L., Christopher, K.A., Greene, A.L., Maliski, S., Swenson, K.K., et al. (2005). Oncology Nursing Society year 2004 research priorities survey. Oncology Nursing Forum, 32, 281-290.

    Berry, J. (1980). Acculturation as varieties of adaptation. In A.M. Padilla (Ed.), Acculturation: Theory, models, and some new findings, (pp. 9-25). Boulder, CO: Westview Press.

    Brislin, R.W. (1970). Back-translation for cross-cultural research. Journal of Cross-Cultural Psychology, 1, 185-216.

    Brislin, R.W. (1986). The wording and translation of research instruments. In W.J. Lonner & J.W. Berry (Eds.), Field methods in cross-cultural research (pp. 137-164). Beverly Hills, CA: Sage.

    Cella, D., Bullinger, M., Scott, C., Barofsky, I., & Clinical Significance Consensus Meeting Group. (2002). Group vs individual approaches to understanding clinical significance of differences or changes in quality of life. Mayo Clinic Proceedings, 77, 384-392.

    Cella, D.F., & Cherin, E.A. (1988). Quality of life during and after cancer treatment. Comprehensive Therapy, 14(5), 69-75.

    Cella, D.F., Tulsky, D.S., Gray, G., Sarafian, B., Linn, E., Bonomi, A., et al. (1993). The Functional Assessment of Cancer Therapy scale: Development and validation of the general measure. Journal of Clinical Oncology, 11, 570-579.

    Chauhan, C., Eppard, W., & Perroti, J. (2004). The patient advocate perspective on assessing the clinical significance for quality-of-life measures. Journal of Cancer Integrative Medicine, 2, 155-157.

    Dijkers, M.P. (2003). Individualization in quality of life measurement: Instruments and approaches. Archives of Physical Medicine and Rehabilitation, 84(4, Suppl. 2), S3-S14.

    Fairclough, D.L. (1997). Summary measures and statistics for comparison of quality of life in a clinical trial of cancer therapy. Statistics in Medicine, 16, 1197-1209.

    Fairclough, D.L. (2004). Patient reported outcomes as endpoints in medical research. Statistical Methods in Medical Research, 13, 115-138.

    Ferrans, C.E. (1990a). Development of a quality of life index for patients with cancer. Oncology Nursing Forum, 17(3, Suppl.), 15-19.

    Ferrans, C.E. (1990b). Quality of life: Conceptual issues. Seminars in Oncology Nursing, 6, 248-254.

    Ferrans, C.E., & Powers, M.J. (1985). Quality of life index: Development and psychometric properties. Advances in Nursing Science, 8(1), 15-24.

    Fong, D., Lam, K.F., Kwan, C.W., Sham, J.S., & Karlberg, J.P. (2004). False positive error in the analysis of paired quality of life data [Abstract 1330]. Quality of Life Research, 13, 1521.

    Frost, M.H., Bonomi, A.E., Ferrans, C., Wong, G.Y., Hays, R.D., & Clinical Significance Consensus Meeting Group. (2002). Patient, clinician, and population perspectives on determining the clinical significance of quality-of-life scores. Mayo Clinic Proceedings, 77, 488-494.

    Guyatt, G.H., Osoba, D., Wu, A.W., Wyrwich, K.W., Norman, G.R., & Clinical Significance Consensus Meeting Group. (2002). Methods to explain the clinical significance of health status measures. Mayo Clinic Proceedings, 77, 371-383.

    Haberman, M.R., & Bush, N. (2003). Quality of life methodological and measurement issues. In C.R. King & P.S. Hinds (Eds.), Quality of life from nursing and patient perspectives: Theory, research, practice (2nd ed., pp. 171-198). Sudbury, MA: Jones and Bartlett.

    Hays, R.D., Anderson, R.T., & Revicki, D. (1998). Assessing reliability and validity of measurement in clinical trials. In M.J. Staquet, R.D. Hays, & P.M. Fayers (Eds.), Quality of life assessment in clinical trials: Methods and practice (pp. 169-182). Oxford, England: Oxford University Press.

    Hays, R.D., & Woolley, J.M. (2000). The concept of clinically meaningful difference in health-related quality-of-life research: How meaningful is it? Pharmacoeconomics, 18, 419-423.

    Hymovich, D.P. (2004). Measurement issues with children and adolescents. In M. Frank-Stromborg & S.J. Olsen (Eds.), Instruments for clinical health-care research (3rd ed., pp. 33-46). Sudbury, MA: Jones and Bartlett.

    Jaeschke, R., Singer, J., & Guyatt, G.H. (1989). Measurement of health status. Ascertaining the minimal clinically important difference. Controlled Clinical Trials, 10, 407-415.

    Kazdin, A.E. (1999). The meanings and measurement of clinical significance. Journal of Consulting Clinical Psychology, 67, 332-339.

    Kendall, P.C., Marrs-Garcia, A., Nath, S.R., & Sheldrick, R.C. (1999). Normative comparisons for the evaluation of clinical significance. Journal of Consulting and Clinical Psychology, 67, 285-299.

    King, C.R., Haberman, M., Berry, D.L., Bush, N., Butler, L., Dow, K.H., et al. (1997). Quality of life and the cancer experience: The state-of-the-knowledge. Oncology Nursing Forum, 24, 27-41.

    King, C.R., & Hinds, P.S. (Eds.). (2003). Quality of life from nursing and patient perspectives: Theory, research, practice (2nd ed.). Sudbury, MA: Jones and Bartlett.

    Marin, G., & Marin, B.V. (1991). Research with Hispanic populations. Newbury Park, CA: Sage.

    Mayo Clinic. (2002). Symposium on the clinical significance of quality of life measures in cancer patients. Mayo Clinic Proceedings, 77(Suppl.), 367-563.

    McHorney, C.A., & Tarlov, A.R. (1995). Individual-patient monitoring in clinical practice: Are available health status surveys adequate? Quality of Life Research, 4, 293-307.

    McMillan, S.C., & Small, B.J. (2002). Symptom distress and quality of life in patients with cancer newly admitted to hospice home care. Oncology Nursing Forum, 29, 1421-1428.

    McMillan, S.C., & Weitzner, M. (1998). Quality of life in cancer patients: Use of a revised Hospice Index. Cancer Practice, 6, 282-288.

    Moinpour, C.M., Sawyers Triplett, J., McKnight, B., Lovato, L.C., Upchurch, C., Leichman, C.G., et al. (2000). Challenges posted by non-random missing quality of life data in an advanced-stage colorectal cancer clinical trial. Psycho-Oncology, 9, 340-354.

    Montero, D. (1977). Research among racial and cultural minorities: An overview. Journal of Social Issues, 33(4), 1-10.

    Omery, A.K., & Dean, H. (2004). Multiple instruments for measuring quality of life. In M. Frank-Stromborg & S.J. Olsen (Eds.), Instruments for clinical health-care research (3rd ed., pp. 150-161). Sudbury, MA: Jones and Bartlett.

    Osoba, D., Rodrigues, G., Myles, J., Zee, B., & Pater, J. (1998). Interpreting the significance of changes in health-related quality-of-life scores. Journal of Clinical Oncology, 16, 139-144.

    Padilla, G.V., Frank-Stromborg, M., & Koresawa, S. (2004). Single instruments for measuring quality of life. In M. Frank-Stromborg & S.J. Olsen (Eds.), Instruments for clinical health-care research (3rd ed., pp. 128-163). Sudbury, MA: Jones and Bartlett.

    Patrick, D.L., & Chiang, Y.P. (2000). Measurement of health outcomes in treatment effectiveness evaluations: Conceptual and methodological challenges. Medical Care, 38(9, Suppl.), II14-II25.

    Rasin, J.H. (2004). Measurement issues with the elderly. In M. Frank-Stromborg & S.J. Olsen (Eds.), Instruments for clinical health-care research (3rd ed., pp. 47-55). Sudbury, MA: Jones and Bartlett.

    Redelmeier, D.A., & Tversky, A. (1990). Discrepancy between medical decisions for individual patients and for groups. New England Journal of Medicine, 322, 1162-1164.

    Ropka, M.E., Guterbock, T., Krebs, L., Murphy-Ende, K., Stetz, K., Summers, B., et al. (2002). Year 2000 Oncology Nursing Society research priorities survey. Oncology Nursing Forum, 29, 481-491.

    Rubenstein, L.V. (1996). Using quality of life tests for the patient diagnosis or screening or to evaluate treatment. In B. Spilker (Ed.), Quality of life and pharmacoeconomics in clinical trials (2nd ed., pp. 363-374). Philadelphia: Lippincott-Raven.

    Samsa, G., Edelman, D., Rothman, M.L., Williams, G.R., Lipscomb, J., & Matchar, D. (1999). Determining clinically important differences in health status measures: A general approach with illustration to the Health Utilities Index Mark II. Pharmacoeconomics, 15, 141-155.

    Sloan, J.A., Aaronson, N., Cappelleri, J.C., Fairclough, D.L., Varricchio, C.G., & Clinical Significance Consensus Meeting Group. (2002). Assessing the clinical significance of single items relative to summated scores. Mayo Clinic Proceedings, 77, 479-487.

    Sloan, J.A., Cella, D., Frost, M., Guyatt, G.H., Sprangers, M., Symonds, T., et al. (2002). Assessing clinical significance in measuring oncology patient quality of life: Introduction to the symposium, content overview, and definition of terms. Mayo Clinic Proceedings, 77, 367-370.

    Sloan, J.A., Loprinzi, C.L., Kuross, S.A., Miser, A.W., O'Fallon, J.R., Mahoney, M.R., et al. (1998). Randomized comparison of four tools measuring overall quality of life in patients with advanced cancer. Journal of Clinical Oncology, 16, 3662-3673.

    Sloan, J.A., & Varricchio, C. (2001). Quality of life endpoints in prostate chemoprevention trials. Urology, 57(4, Suppl. 1), 235-240.

    Spitzer, W.O., Dobson, A.J., Hall, J., Chesterman, E., Levi, J., Shepherd, R., et al. (1981). Measuring the quality of life of cancer patients: A concise QL index for use by physicians. Journal of Chronic Diseases, 34, 585-597.

    Sprangers, M.A., Moinpour, C.M., Moynihan, T.J., Patrick, D.L., Revicki, D.A., & Clinical Significance Consensus Meeting Group. (2002). Assessing meaningful changes in quality of life over time: A users' guide for clinicians. Mayo Clinic Proceedings, 77, 561-571.

    Sprangers, M.A., & Schwartz, C.E. (1999). The challenge of response shift for quality-of-life-based clinical oncology research. Annals of Oncology, 10, 747-749.

    Sprangers, M.A., van Dam, F.S., Broersen, J., Lodder, L., Wever, L., Visser, M.R., et al. (1999). Revealing response shift in longitudinal research on fatigue—The use of the thentest approach. Acta Oncologica, 38, 709-718.

    Symonds, T., Berzon, R., Marquis, P., Rummans, T.A., & Clinical Significance Consensus Meeting Group. (2002). The clinical significance of quality of life results: Practical considerations for specific audiences. Mayo Clinic Proceedings, 77, 572-583.

    Vallerand, A.H., & Payne, J.K. (2003). Theories and conceptual models to guide quality of life related research. In C.R. King & P.S. Hinds (Eds.), Quality of life from nursing and patient perspectives: Theory, research, practice (2nd ed., pp. 45-64). Sudbury, MA: Jones and Bartlett.

    Varricchio, C.G. (2004). Measurement issues concerning linguistic translations. In M. Frank-Stromborg & S.J. Olsen (Eds.), Instruments for clinical health-care research (3rd ed., pp. 56-64). Sudbury, MA: Jones and Bartlett.

    Ware, J.E., Jr. (2003). Conceptualization and measurement of health-related quality of life: Comments on an evolving field. Archives of Physical Medicine and Rehabilitation, 84(4, Suppl. 2), S43-S51.

    Ware, J.E., Jr., Kosinski, M., & Keller, S.D. (1994). SF 36 physical and mental health summary scales: A user's manual. Boston: New England Medical Center.

    Warnecke, R.B., Ferrans, C.E., Johnson, T.P., Chapa-Resendez, G., O'Rourke, D.P., Chavez, N., et al. (1996). Measuring quality of life in culturally diverse populations. Journal of the National Cancer Institute Monographs, 20, 29-38.

    Westerman, M.J., & Hak, T. (2004). Response shift in quality of life in patients with small cell lung cancer [Abstract 1196]. Quality of Life Research, 13, 1521.

    World Health Organization. (1993). WHO QOL study protocol: The development of the World Health Organization quality of life assessment instrument (Publication No. MNH/PSF/93.9). Geneva, Switzerland: Author.

    Wyrwich, K.W., Bullinger, M., Aaronson, N., Hays, R.D., Patrick, D.L., Symonds, T., et al. (2005). Estimating clinically significant differences in quality of life outcomes. Quality of Life Research, 14, 185-295.